Cinnamomum bejolghota
Cinnamomum bejolghota
Cinnamomum bejolghota is a plant traditionally used primarily in Ayurvedic medicine, though specific uses are not well-documented. Scientific studies have shown potential for Cinnamomum bejolghota and related plants in inhibiting α-glucosidase and α-amylase activities, which could be beneficial for managing blood sugar levels. Additionally, research has identified seven new compounds from this plant that exhibit antioxidant properties and inhibit cancer cell growth. The leaves of the plant have yielded new alkaloid and sesquiterpenoid compounds, with only rutin showing moderate inhibitory activity against MCF-7 breast cancer cells. A polar fraction (Fr.M1) from Cinnamomum bejolghota has also demonstrated inhibition of T3SS effector protein secretion and alleviation of inflammatory symptoms in mice without affecting bacterial growth. To date, no major safety issues or drug interactions have been recorded for this plant.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The polar fraction Fr.M1 from Cinnamomum bejolghota inhibited T3SS effector protein secretion and alleviated inflammatory symptoms in mice, without affecting bacterial growth.
- Seven new lignans and neolignans were isolated from Cinnamomum bejolghota, showing comparable antioxidant activity and inhibitory effects on cancer cell proliferation.
- Cinnamomum bejolghota, among other plants, showed potential in inhibiting α-glucosidase and α-amylase activities.
- Cinnamomum bejolghota leaves yielded new alkaloid and sesquiterpenoid compounds, with only rutin showing moderate cytotoxic activity against MCF-7 cells.
Frequently asked questions
What is Cinnamomum bejolghota?
Cinnamomum bejolghota (Cinnamomum bejolghota) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Cinnamomum bejolghota?
4 sourced findings are recorded for Cinnamomum bejolghota; the strongest carries evidence grade D. For example: The polar fraction Fr.M1 from Cinnamomum bejolghota inhibited T3SS effector protein secretion and alleviated inflammatory symptoms in mice, without affecting bacterial growth.
How strong is the evidence for Cinnamomum bejolghota?
The strongest finding for Cinnamomum bejolghota carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Cinnamomum bejolghota safe? What are the side effects?
No major safety issues are recorded for Cinnamomum bejolghota in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Cinnamomum bejolghota interact with medications?
No drug interactions are recorded for Cinnamomum bejolghota in our sources. This does not rule them out — check with a pharmacist.
Is Cinnamomum bejolghota a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Lignans and Neolignans with Antioxidant and Human Cancer Cell Proliferation Inhibitory Activities from Cinnamomum bejolghota Confirm Its Functional Food Property. literature abstract metadata
- T2 The in vitro and in vivo anti-virulence activities of Cinnamomum bejolghota by inhibiting type three secretion system effector proteins of Salmonella. literature abstract metadata
- T2 Evaluating the Hypoglycemic Efficacy and Quality Assurance of Ya That Opchoei Mixture. literature abstract metadata
- T2 New Alkaloid and Sesquiterpenoid From the Leaves of Cinnamomum bejolghota. literature abstract metadata